BIRC6 and metastatic malignant neoplasm in the lymph nodes: Increased BIRC6 expression in non-small cell lung cancer (NSCLC) is linked to an advanced pathological T stage, poor differentiation, and lymph node metastasis, and may be associated with tumor progression.